scPharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update Pharmaceutical Investing
PreveCeutical Signs Non-Disclosure Agreement with World Leading Specialized Drug Delivery Device Manufacture Biotech Investing
Auris Medical Receives Positive Scientific Advice from EMA on Development Plan and Regulatory Pathway for AM-111 Pharmaceutical Investing
Aclaris Therapeutics Announces Availability of ESKATA (Hydrogen Peroxide) Topical Solution, 40% (w/w) Pharmaceutical Investing
Cytori Provides Update on US Manufacturing and EU Approval Plans for ATI-0918, Liposomal Doxorubicin Pharmaceutical Investing
Ultragenyx and Kyowa Kirin Announce Crysvita Now Launched in the U.S. for the Treatment of X–linked Hypophosphatemia Pharmaceutical Investing
Genocea Files Investigational New Drug Application for Neoantigen Cancer Vaccine Candidate GEN-009 Pharmaceutical Investing
Daré Bioscience announces funding award to further the development of Ovaprene Pharmaceutical Investing
